To explore the clinical significance of the IL-6/IL-6R pathway in HNSCC, differences in downstream pathway expression between ‘High’ and ‘Low’ IL-6/IL-6R groups were analysed using TCGA data from 115 primary tumour samples. The gene discussed is IL6; the disease is head and neck squamous cell carcinoma.